Gateway 2012: Hamilton Company - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Hamilton Company


Hamilton Company
4970 Energy Way
Reno, NV 89502
Contact: Amber Ratcliff / Marketing Manager
Phone: 800-648-5950
URL: www.hamiltoncompany.com/Sensors

Company Description:

Hamilton Company is a global enterprise with manufacturing facilities in Reno, Nevada and Bonaduz, Switzerland. We are the worldwide leader in the design and manufacturing of manual, semi-automated, and robotic products for liquid handling as well as analytical detection. We offer a complete line of high quality pH, redox, conductivity, and oxygen electrodes for laboratory and process measurement. For over 50 years, we’ve been satisfying customers by combining quality materials with skilled workmanship, ensuring the highest level of performance to every device we manufacture. Hamilton’s lifelong commitment to accuracy and quality has earned us a global ISO 9001 certification.

INTERPHEX 2012 Booth Preview:

Hamilton Company manufactures application-oriented pH, ORP, dissolved oxygen, and conductivity sensors distinguished by their high quality, long life, and competitive price. Our intelligent VISIFERM optical dissolved oxygen probe offers technology that sets new standards in DO measurement. The new Hamilton ARC revolutionizes process analytics by replacing the traditional transmitter with a microprocessor within the sensor. ARC sensors measure more reliably as well as save on cost because they communicate directly with the process control system. Stop by our INTERPHEX 2012 booth # 3564 to discover more innovations from Hamilton.

Online PDF Documents:
Hamilton ARC Catalog
Hamilton Process Sensors Catalog

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
9%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here